Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
D035843:Biomedical Research; D006261:Headache / Q000517:prevention & control*; D008237:Lysergic Acid; D008238:Lysergic Acid Diethylamide / Q000031:analogs & derivatives; D008784:Methysergide
C034985:1-methyllysergic acid butanolamide; D008238:Lysergic Acid Diethylamide; D008237:Lysergic Acid; D008784:Methysergide
HEADACHE/prevention and control; LYSERGIC ACID DIETHYLAMIDE/related compounds